UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030006
Receipt number R000034203
Scientific Title pharmacokinetics and pharmacodynamics study of intraveneous acetaminophen
Date of disclosure of the study information 2017/11/20
Last modified on 2021/04/14 10:09:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

pharmacokinetics and pharmacodynamics study of intraveneous acetaminophen

Acronym

pharmacokinetics and pharmacodynamics study of intraveneous acetaminophen

Scientific Title

pharmacokinetics and pharmacodynamics study of intraveneous acetaminophen

Scientific Title:Acronym

pharmacokinetics and pharmacodynamics study of intraveneous acetaminophen

Region

Japan


Condition

Condition

Patients who undergo head neck and oral surgery without nerve block or epidural anesthesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate impact of differences in the administration rate of acetaminophen intraveneous drug and examine the relationship between pharmacokinetics and pharmacodynamics

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase III


Assessment

Primary outcomes

Blood concentration of acetaminophen

Key secondary outcomes

VRS VAS NRS


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

ASA 1 and 2
Adult patient with good condition

Key exclusion criteria

1.History of allergy to acetaminophen
2.History of aspirin asthma
3.Oral use of carbamazepine/phenobarbital/phenytoin/primidone/rifampicin
4.Psychoneurotic disorders
5.Psychiatric pharmacotherapy
6.Liver or advanced renal dysfunction
7.Alcohol drinkers and adddiction patient
8.Pregnant woman/breast-feeding
9.Those who were considered inadequate

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Tomoko
Middle name
Last name Suzuki

Organization

Tohoku University

Division name

Department of Anesthesiology and Perioperative Medicine

Zip code

980-8574

Address

1-1 seiryoumachi aobaku sendai miyagi

TEL

0227177321

Email

tomoko.suzuki.r2@dc.tohoku.ac.jp


Public contact

Name of contact person

1st name Tomoko
Middle name
Last name Suzuki

Organization

Tohoku University

Division name

Department of Anesthesiology and Perioperative Medicine

Zip code

980-8574

Address

1-1 seiryoumachi aobaku sendai miyagi

TEL

0227177321

Homepage URL


Email

tomoko.suzuki.r2@dc.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Tohoku University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Sendai Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tohoku University

Address

1-1 Seiryoumachi Aobaku Sendai Miyagi Japan

Tel

0227177321

Email

tomoko.suzuki.r2@dc.tohoku.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

29-55 20-64

Org. issuing International ID_1

National Hospital Organization Sendai Medical Center

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

仙台医療センター(宮城県)


Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

51

Results

As a result of examining the results of NRS in 3 groups and postoperative analgesics and the characteristics of the blood concentration transition curve, when intravenous APAP 1000 mg is used intraoperatively and postoperatively, the analgesic effect was high with the administration method that combined rapid single administration and continuous administration.

Results date posted

2021 Year 04 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Healthy adult patients undergoing minor oral surgery under general anesthesia at Sendai Medical Center (American Society of Anesthesia Preoperative Status Classification ASA physical status I-II)

Participant flow

Tohoku University Ethics Committee and National Hospital Organization Sendai Medical Center Ethics Committee after approval, oral and written explanations with consent, the patient himself signed the consent form in writing.

Adverse events

no

Outcome measures

Use of NRS and postoperative analgesics up to 240 minutes after dosing and Cmax, tmax, AUC, effective blood concentration arrival time, effective blood concentration maintenance time according to the drawn plasma concentration transition curve.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 23 Day

Date of IRB

2017 Year 10 Month 23 Day

Anticipated trial start date

2017 Year 11 Month 20 Day

Last follow-up date

2021 Year 11 Month 30 Day

Date of closure to data entry

2021 Year 11 Month 30 Day

Date trial data considered complete

2021 Year 11 Month 30 Day

Date analysis concluded

2021 Year 11 Month 30 Day


Other

Other related information

Observe intravenous acetaminophen blood concentration and analgesic effect after acetaminophen infusion


Management information

Registered date

2017 Year 11 Month 16 Day

Last modified on

2021 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034203


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name